[1] WARDLAW J M，SMITH C，DICHGANS M.

Mechanisms of sporadic cerebral small vessel disease：

insights from neuroimaging[J]. Lancet Neurol，2013，

12（5）：483-497.

[2] WARDLAW J M，SMITH E E，BIESSELS G J，et

al. Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurol，2013，12（8）：

822-838.

[3] VAN VELUW S J，SHIH A Y，SMITH E E，et al.

Detection，risk factors，and functional consequences

of cerebral microinfarcts[J]. Lancet Neurol，2017，16

（9）：730-740.

[4] LOW A，MAK E，STEFANIAK J D，et al. Peak

width of skeletonized mean diffusivity as a marker

of diffuse cerebrovascular damage[J/OL]. Front

Neurosci，2020，14：238[2020-06-15]. https：//doi.

org/10.3389/fnins.2020.00238.

[5] CROALL I D，LOHNER V，MOYNIHAN B，et al.

Using DTI to assess white matter microstructure in

cerebral small vessel disease（SVD）in multicentre

studies[J]. Clin Sci（Lond），2017，131（12）：1361-

1373.

[6] YE Q，BAI F. Contribution of diffusion，perfusion

and functional MRI to the disconnection hypothesis

in subcortical vascular cognitive impairment[J].

Stroke Vasc Neurol，2018，3（3）：131-139.

[7] HE Y，CHEN Z J，EVANS A C，Small-world

anatomical networks in the human brain revealed by

cortical thickness from MRI[J]. Cereb Cortex，2007，

17（10）：2407-2419.

[8] TULADHAR A M，VAN DIJK E，ZWIERS M P，et

al. Structural network connectivity and cognition in

cerebral small vessel disease[J]. Hum Brain Mapp，

2016，37（1）：300-310.

[9] LEE M H，SMYSER C D，SHIMONY J S. Restingstate

fMRI：a review of methods and clinical

applications[J]. AJNR Am J Neuroradiol，2013，34

（10）：1866-1872.

[10] LAVDAS I，GLOCKER B，RUECKERT D，et al.

Machine learning in whole-body MRI：experiences

and challenges from an applied study using

multicentre data[J]. Clin Radiol，2019，74（5）：346-

356.

[11] HSIEH Y Z，LUO Y C，PAN C，et al. Cerebral

small vessel disease biomarkers detection on MRIsensor-

based image and deep learning[J/OL]. Sensors

（Basel），2019，19（11）：2573[2020-06-15]. https：//

doi.org/10.3390/s19112573.

[12] LAMBERT C，SAM NAREAN J，BENJAMIN P，

et al. Characterising the grey matter correlates of

leukoaraiosis in cerebral small vessel disease[J/OL].

Neuroimage Clin，2015，9：194-205[2020-06-15].

https：//doi.org/10.1016/j.nicl.2015.07.002.

[13] CIULLI S，CITI L，SALVADORI E，et al.

Prediction of impaired performance in trail making

test in MCI patients with small vessel disease using

DTI data[J]. IEEE J Biomed Health Inform，2016，20

（4）：1026-1033.

[14] PANTONI L，MARZI C，POGGESI A，et al. Fractal

dimension of cerebral white matter：a consistent

feature for prediction of the cognitive performance

in patients with small vessel disease and mild

cognitive impairment[J/OL]. Neuroimage Clin，2019，

24：101990[2020-06-15]. https：//doi.org/10.1016/

j.nicl.2019.101990.

[15] PROMJUNYAKUL N O，LAHNA D L，KAYE

J A，et al. Comparison of cerebral blood flow and

structural penumbras in relation to white matter

hyperintensities：a multimodal magnetic resonance

imaging study[J]. J Cereb Blood Flow Metab，2016，

36（9）：1528-1536.

[16] SHI Y L，THRIPPLETON M J，MAKIN S D，et

al. Cerebral blood flow in small vessel disease：a

systematic review and meta-analysis[J]. J Cereb

Blood Flow Metab，2016，36（10）：1653-1667.

[17] BLAIR G W，HERNANDEZ M V，THRIPPLETON

M J，et al. Advanced neuroimaging of cerebral small

vessel disease[J]. Curr Treat Options Cardiovasc

Med，2017，19（7）：56.

[18] DUMAS A，DIERKSEN G A，GUROL M E，et al.

Functional magnetic resonance imaging detection of

vascular reactivity in cerebral amyloid angiopathy[J].

Ann Neurol，2012，72（1）：76-81.

[19] LI Y，LI M，ZHANG X Y，et al. Higher blood-brain

barrier permeability is associated with higher white

matter hyperintensities burden[J]. J Neurol，2017，

264（7）：1474-1481.

[20] ZHANG C E，WONG S M，VAN DE HAAR H J，et

al. Blood-brain barrier leakage is more widespread

in patients with cerebral small vessel disease[J].

Neurology，2017，88（5）：426-432.